Delivery Order SPE2DB22D1017-SPE2DB24FF4HP
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX RABIES VACCINE VIALS. The award has a potential value of $9,834.96 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. This delivery order is issued under a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMOVAX RABIES VACCINE VIALS. The contract has a potential value of $5,866.77 and a completion date of March 7, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply IMOVAX Rabies Vaccine vials. The contract has a ceiling value of $8,141.77 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine vials. The contract has a potential value of $5,267.14 and a completion date of February 21, 2024. This award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine vials. The $2,590.44 order has a completion date of January 9, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous DLA contracts to supply pharmaceuticals, medical supplies, and distribution services. This delivery order is part of the company's...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of IMOVAX Rabies Vaccine Vials, a firm fixed-price delivery order with a potential value of $1,138.52 and a completion date of February 21, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,158.70 firm-fixed price delivery order is for the supply of IMOVAX Rabies Vaccine vials. The contract has an ultimate completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as the primary...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract, valued at $3,669.79, is for the provision of IMOVAX Rabies Vaccine vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide the Defense Logistics Agency (DLA) Troop Support Medical with IMOVAX Rabies Vaccine vials. The firm fixed price delivery order, valued at $22,540.64, has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is an established supplier of pharmaceuticals and medical supplies to various U.S. government...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,472,780 Imovax rabies vaccine vials. The $5,612.62 contract has a completion date of January 30, 2024. This delivery order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4HPDelivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/15/24 |